Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

2020
- ASCO 2020 - Lung Cancer
2019
- ASH 2019 - CLL
- ASCO 2019 - CLL
2018
- ASH 2018 CLL
- ID Week 2018
2017
2016
- ASH 2016 - Chronic Lymphocytic Leukemia
- ASH 2016 - Multiple Myeloma

ASCO 2020 Lung Cancer Highlights

Impact of Immune-Related Adverse Events on Checkpoint Inhibitor Consolidation Therapy in Stage III NSCLC

Characteristics of Patients Who Achieve Long-Term Response with PD-1 Blockade

Smoking Cessation and Lung Cancer: Recent Quitters Benefit Too

Weekly Epirubicin as Second-Line Therapy for Malignant Pleural Mesothelioma

Patterns of Acquired Resistance in Patients with NSCLC Who Receive PD-1 Inhibitors

ADAURA Results: Osimertinib as Adjuvant Therapy for EGFR-Mutated NSCLC

Cediranib Combined with Olaparib Is Active in Patients with Platinum-Pretreated SCLC

Nationwide Genomic Screening Network Can Be Effective in Identifying Rare Targetable Genetic Alterations

Combination of Nivolumab, Ipilimumab, and Chemotherapy in Metastatic NSCLC

1
2
3
4

Page 1 of 25
Results 1 - 10 of 242

SUBSCRIBE

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Special Print Editions

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.